novel SARS-CoV-2

A recent collaborative study from the USA, UK and France has identified the proteins on human host cells that interact with the SARS-CoV-2 virus on infection. Among these proteins, researchers have identified the human proteins that are already targeted by existing drugs or compounds and can therefore be tested as antiviral therapeutics.